Two medical therapies elevated to front line in 2021 update HF ECDP
This video was recorded in response to the recent publication of the 2021 update to the 2017 HF ECDP.
James Januzzi is a member of the Massachusetts General Hospital Cardiology Division where he is the Roman W. DeSanctis Endowed Distinguished Clinical Scholar in Medicine. He is also the Hutter Family Professor of Medicine at Harvard Medical School and is on faculty at the Harvard Clinical Research Institute, Boston, MA, USA.
This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: